Click image to open full size
Neurotransmitter Systems
Types, Receptors, and Clinical Implications
Related Tools
Related Labs
Related Worksheets
Neurotransmitters are chemical messengers that let neurons communicate across synapses, linking electrical signals in one cell to chemical signals in another. These systems control movement, mood, attention, sleep, pain, memory, and autonomic function. Understanding the major neurotransmitters helps students connect basic neurobiology to symptoms, drug actions, and disease mechanisms. It is a core foundation for neuroscience, pharmacology, psychiatry, and clinical medicine.
At a synapse, an action potential triggers Ca2+ entry into the presynaptic terminal, causing vesicles to release neurotransmitter into the synaptic cleft. The transmitter then binds ionotropic or metabotropic receptors on the postsynaptic cell, changing membrane potential or intracellular signaling. The signal ends by reuptake, enzymatic breakdown, or diffusion, and many drugs work by altering one of these steps. Clinical effects depend on which transmitter is involved, which receptor subtype is activated, and where in the nervous system the pathway is located.
Key Facts
- Synaptic release is triggered when depolarization opens voltage gated Ca2+ channels in the presynaptic terminal.
- Ionotropic receptors are ligand gated ion channels that act in milliseconds, while metabotropic receptors are G protein coupled receptors that act more slowly.
- Excitatory postsynaptic potentials often involve Na+ or Ca2+ entry, while inhibitory postsynaptic potentials often involve Cl- entry or K+ exit.
- Acetylcholine acts at nicotinic receptors in the neuromuscular junction and autonomic ganglia, and at muscarinic receptors in parasympathetic target organs.
- Dopamine pathways include nigrostriatal for movement, mesolimbic for reward, mesocortical for cognition, and tuberoinfundibular for prolactin regulation.
- A common membrane relation is I = g(Vm - Eion), where synaptic current depends on conductance and the difference between membrane potential and ion equilibrium potential.
Vocabulary
- Synapse
- A synapse is the junction where one neuron communicates with another cell by releasing neurotransmitter.
- Neurotransmitter
- A neurotransmitter is a chemical messenger released by a neuron that binds receptors on a target cell.
- Ionotropic receptor
- An ionotropic receptor is a receptor that directly opens an ion channel when a neurotransmitter binds.
- Metabotropic receptor
- A metabotropic receptor is a G protein coupled receptor that changes cell activity through second messenger signaling.
- Reuptake
- Reuptake is the process by which released neurotransmitter is transported back into the presynaptic neuron or nearby glial cells.
Common Mistakes to Avoid
- Assuming one neurotransmitter is always excitatory or always inhibitory, which is wrong because the effect depends on the receptor subtype and target cell ion channels. For example, acetylcholine can excite skeletal muscle but slow the heart through different receptors.
- Confusing ionotropic and metabotropic receptors, which is wrong because they differ in mechanism and time course. Ionotropic receptors directly gate ion flow, while metabotropic receptors signal through G proteins and second messengers.
- Thinking dopamine deficiency causes all dopamine related disorders, which is wrong because too little or too much signaling in different pathways produces different symptoms. Parkinson disease, psychosis, and hyperprolactinemia involve different dopamine circuit problems.
- Ignoring how signals are terminated, which is wrong because reuptake and enzymatic breakdown strongly shape synaptic effects and drug responses. Many important medications act by blocking transporters or enzymes rather than by mimicking the transmitter itself.
Practice Questions
- 1 A synapse releases a neurotransmitter that opens a postsynaptic Cl- channel. If the postsynaptic membrane potential is -60 mV and ECl is -70 mV, will the membrane tend to depolarize or hyperpolarize when the channel opens? State the direction of change.
- 2 A patient is given a drug that inhibits acetylcholinesterase. If 120 acetylcholine molecules would normally remain in the cleft for 2 ms, predict whether the duration of receptor activation will increase or decrease and explain the likely effect at the neuromuscular junction.
- 3 A drug blocks dopamine D2 receptors in the tuberoinfundibular pathway. Explain why this can raise prolactin levels even though the same drug may reduce psychotic symptoms through a different dopamine pathway.